Passive immunization of Alzheimer's disease
US6913745B1 · kind B1 · utility
99Cited by
79References
60Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 1, 2000 |
| Grant date | Jul 5, 2005 |
| Priority date | — |
| Expiry date | Jun 1, 2020 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2821
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are pharmaceutical compositions and methods for preventing or treating a number of amyloid diseases, including Alzheimer's disease, prion diseases, familial amyloid neuropathies and the like. The pharmaceutical compositions include immunologically reactive amounts of amyloid fibril components, particularly fibril-forming peptides or proteins. Also disclosed are therapeutic compositions and methods which use immune reagents that react with such fibril components.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.